![](/img/cover-not-exists.png)
Cost utility of allogeneic stem cell transplantation with matched unrelated donor versus treatment with imatinib for adult patients with newly diagnosed chronic myeloid leukaemia
Breitscheidel, LusineVolume:
11
Language:
english
Journal:
Journal of Medical Economics
DOI:
10.3111/13696990802354683
Date:
December, 2008
File:
PDF, 746 KB
english, 2008